140 related articles for article (PubMed ID: 15512970)
1. Efficacy of antiviral agents in feline herpetic keratitis: results of an in vitro study.
Williams DL; Fitzmaurice T; Lay L; Forster K; Hefford J; Budge C; Blackmore K; Robinson JC; Field HF
Curr Eye Res; 2004; 29(2-3):215-8. PubMed ID: 15512970
[TBL] [Abstract][Full Text] [Related]
2. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
Andrei G; De Clercq E; Snoeck R
Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
Maudgal PC; De Clercq E; Huyghe P
Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
[TBL] [Abstract][Full Text] [Related]
4. Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase.
Hussein IT; Menashy RV; Field HJ
Antiviral Res; 2008 Jun; 78(3):268-74. PubMed ID: 18325606
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of cycloSal-nucleoside monophosphates and polyhydroxycarboxylates against orthopoxviruses.
Sauerbrei A; Meier C; Meerbach A; Schiel M; Helbig B; Wutzler P
Antiviral Res; 2005 Sep; 67(3):147-54. PubMed ID: 16076502
[TBL] [Abstract][Full Text] [Related]
6. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical aciclovir for the treatment of feline herpetic keratitis: results of a prospective clinical trial and data from in vitro investigations.
Williams DL; Robinson JC; Lay E; Field H
Vet Rec; 2005 Aug; 157(9):254-7. PubMed ID: 16127135
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine.
Nasisse MP; Guy JS; Davidson MG; Sussman W; De Clercq E
Am J Vet Res; 1989 Jan; 50(1):158-60. PubMed ID: 2493210
[TBL] [Abstract][Full Text] [Related]
9. Development of a quantitative real-time TaqMan PCR assay for testing the susceptibility of feline herpesvirus-1 to antiviral compounds.
Hussein IT; Field HJ
J Virol Methods; 2008 Sep; 152(1-2):85-90. PubMed ID: 18597862
[TBL] [Abstract][Full Text] [Related]
10. Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases.
Sundmacher R
Metab Pediatr Syst Ophthalmol; 1983; 7(2):89-94. PubMed ID: 6686278
[TBL] [Abstract][Full Text] [Related]
11. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
12. In vitro cytotoxicity and antiviral efficacy against feline herpesvirus type 1 of famciclovir and its metabolites.
Groth AD; Contreras MT; Kado-Fong HK; Nguyen KQ; Thomasy SM; Maggs DJ
Vet Ophthalmol; 2014 Jul; 17(4):268-74. PubMed ID: 24112415
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of three antiviral drugs in mice herpetic keratitis.
Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
Jpn J Ophthalmol; 1989; 33(1):125-31. PubMed ID: 2543857
[TBL] [Abstract][Full Text] [Related]
14. A-5021: a new acyclovir analogue inhibits murine herpetic keratitis.
Itahashi M; Higaki S; Sugahara D; Sugioka K; Deai T; Takao K; Hayashi K; Shimomura Y
Cornea; 2008 Apr; 27(3):334-8. PubMed ID: 18362663
[TBL] [Abstract][Full Text] [Related]
15. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
Duan R; de Vries RD; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2008 Sep; 198(5):659-63. PubMed ID: 18627246
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of four antiviral agents in the treatment of uncomplicated herpetic keratitis.
Panda A; Das GK; Khokhar S; Rao V
Can J Ophthalmol; 1995 Aug; 30(5):256-8. PubMed ID: 8529160
[TBL] [Abstract][Full Text] [Related]
17. Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis.
Kaufman HE; Haw WH
Curr Eye Res; 2012 Jul; 37(7):654-60. PubMed ID: 22607463
[TBL] [Abstract][Full Text] [Related]
18. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
Schinazi RF; Nahmias AJ
Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
[TBL] [Abstract][Full Text] [Related]
19. Effect of oral valaciclovir on herpetic keratitis.
Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
[TBL] [Abstract][Full Text] [Related]
20. Substrate specificity and molecular modelling of the feline herpesvirus-1 thymidine kinase.
Hussein IT; Miguel RN; Tiley LS; Field HJ
Arch Virol; 2008; 153(3):495-505. PubMed ID: 18196203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
